Your browser doesn't support javascript.
loading
ESMO Clinical Practice Guideline interim update on new targeted therapies in the first line and at relapse of chronic lymphocytic leukaemia.
Eichhorst, B; Ghia, P; Niemann, C U; Kater, A P; Gregor, M; Hallek, M; Jerkeman, M; Buske, C.
Afiliación
  • Eichhorst B; Department I for Internal Medicine, Center for Integrated Oncology Aachen Bonn Köln Düsseldorf, University of Cologne, Cologne, Germany.
  • Ghia P; Medical School, Università Vita-Salute San Raffaele, Milan; Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Niemann CU; Department of Haematology, Rigshospitalet, Copenhagen, Denmark.
  • Kater AP; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Gregor M; Division of Hematology, Luzerner Kantonsspital, Luzern, Switzerland.
  • Hallek M; Department I for Internal Medicine, Center for Integrated Oncology Aachen Bonn Köln Düsseldorf, University of Cologne, Cologne, Germany; Cluster of Excellence-Cologne Excellence on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
  • Jerkeman M; Department of Oncology, Skåne University Hospital and Lund University, Lund, Sweden.
  • Buske C; Institute of Experimental Cancer Research, Comprehensive Cancer Center Ulm (CCCU), University Hospital of Ulm, Ulm, Germany.
Ann Oncol ; 35(9): 762-768, 2024 Sep.
Article en En | MEDLINE | ID: mdl-38969011

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Terapia Molecular Dirigida Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Terapia Molecular Dirigida Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Alemania